MassIVE MSV000095036

Partial Public PXD053122

Analytical insights from FFPE-based proteome profiling of 1,200 pan cancer cases

Description

Proteome profiling of formalin-fixed paraffin-embedded (FFPE) specimens has gained traction in recent years for the analysis of human clinical material, notably cancer tissue for the discovery of molecular biomarkers. However, published reports so far focused on certain cancer entities and comprised a limited number of cases. In addition, no in-depth investigation into the long-term performance of experimental workflows for FFPE proteomics has been reported yet. In study, we assessed a previously published workflow in terms of robustness and scalability by analyzing the proteomes of 1,220 tumor specimens from six cancer entities processed over the course of three years. Important analytical insights include the necessity of introducing a new normalization method that ensures equal and reproducible sample loading for LC-MS/MS analysis across cohorts, the benefit of spiking retention time standards to be able to compare samples across extended periods of time, that tumors can, on average, be profiled to a depth of >5,000 proteins within an acceptable time frame and, surprisingly, that current software is unable to process such large data sets simultaneously. Beyond these analytical insights, this study provides protein expression information on 11,000 proteins in >1,200 tumor samples from six cancer entities representing the first comprehensive pan-cancer proteome resource for FFPE material to date. The authors believe that the current study provides useful guidance for planning large-scale FFPE proteome projects and is also of immediate utility to the scientific community as the data is publicly accessible via a custom-built ShinyApp enabling a wide range of analysis. This includes e. g. the quantitative comparison of proteins of interest between patients or cohorts or the discovery of protein fingerprints that represent the tissue of origin and proteins that are enriched in certain cancer entities. [doi:10.25345/C5JQ0T61T] [dataset license: CC0 1.0 Universal (CC0 1.0)]

Keywords: FFPE ; pan-cancer ; DLBCL ; OSCC ; PDAC ; CRC ; Glioma ; Melanoma ; FAIMS ; proteomics ; large-scale ; clinical proteomics ; cancer ; expression profiles

Contact

Principal Investigators:
(in alphabetical order)
Bernhard Kuster, Technical University of Munich (TUM), Germany
Submitting User: stephan_eckert
Number of Files:
Total Size:
Spectra:
Subscribers:
 
Owner Reanalyses
Experimental Design
    Conditions:
    Biological Replicates:
    Technical Replicates:
 
Identification Results
    Proteins (Human, Remapped):
    Proteins (Reported):
    Peptides:
    Variant Peptides:
    PSMs:
 
Quantification Results
    Differential Proteins:
    Quantified Proteins:
 
Browse Dataset Files
Browse Metadata
 
FTP Download Link (click to copy):

- Dataset Reanalyses


+ Dataset History


Click here to queue conversion of this dataset's submitted spectrum files to open formats (e.g. mzML). This process may take some time.

When complete, the converted files will be available in the "ccms_peak" subdirectory of the dataset's FTP space (accessible via the "FTP Download" link to the right).
Number of distinct conditions across all analyses (original submission and reanalyses) associated with this dataset.

Distinct condition labels are counted across all files submitted in the "Metadata" category having a "Condition" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct biological replicates across all analyses (original submission and reanalyses) associated with this dataset.

Distinct replicate labels are counted across all files submitted in the "Metadata" category having a "BioReplicate" or "Replicate" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct technical replicates across all analyses (original submission and reanalyses) associated with this dataset.

The technical replicate count is defined as the maximum number of times any one distinct combination of condition and biological replicate was analyzed across all files submitted in the "Metadata" category. In the case of fractionated experiments, only the first fraction is considered.

"N/A" means no results of this type were submitted.
Originally identified proteins that were automatically remapped by MassIVE to proteins in the SwissProt human reference database.

"N/A" means no results of this type were submitted.
Number of distinct protein accessions reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct unmodified peptide sequences reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct peptide sequences (including modified variants or peptidoforms) reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Total number of peptide-spectrum matches (i.e. spectrum identifications) reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct proteins quantified across all analyses (original submission and reanalyses) associated with this dataset.

Distinct protein accessions are counted across all files submitted in the "Statistical Analysis of Quantified Analytes" category having a "Protein" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct proteins found to be differentially abundant in at least one comparison across all analyses (original submission and reanalyses) associated with this dataset.

A protein is differentially abundant if its change in abundance across conditions is found to be statistically significant with an adjusted p-value <= 0.05 and lists no issues associated with statistical tests for differential abundance.

Distinct protein accessions are counted across all files submitted in the "Statistical Analysis of Quantified Analytes" category having a "Protein" column in this dataset.

"N/A" means no results of this type were submitted.
This dataset may not contain all raw spectra data as originally deposited in PRIDE. It has been imported to MassIVE for reanalysis purposes, so its spectra data here may consist solely of processed peak lists suitable for reanalysis with most software.